Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard-Robarts Collaboration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00160108
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : March 20, 2018
Sponsor:
Collaborators:
Harvard School of Public Health
University of Western Ontario, Canada
Soroka University Medical Center
Brigham and Women's Hospital
Harvard Medical School
The Nuclear Research Center, Dimona
Ben-Gurion University of the Negev
Information provided by:
The S. Daniel Abraham International Center for Health and Nutrition

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Aim-to conduct a randomized clinical intervention study to compare three diets (low-fat, low-carbohydrate and Mediterranean diet) for weight loss

Condition or disease Intervention/treatment Phase
Obesity CHD Behavioral: dietary intervention Phase 1

Detailed Description:
Aim-to conduct a randomized clinical intervention study to compare three diets (low-fat, low-carbohydrate and Mediterranean diet) for weight loss
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 300 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Actual Study Start Date : July 2005
Actual Study Completion Date : July 2007
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. weight loss

Secondary Outcome Measures :
  1. CVD mediators measurements

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI>27
  • age>40
  • History of CHD or diabetes in any age or BMI level

Exclusion Criteria:

  • Pregnant or lactating women.
  • Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
  • Serum creatinine > 3 mg/dl.
  • Liver dysfunction ( ³ 2 fold level of ALT and AST enzymes).
  • Participation in another trial in which active intervention is being received.
  • Any intestinal problem that would prevent the patient from eating one of the test diets (for example, gastric stapling that might prevent consumption of vegetables).
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00160108


Locations
Layout table for location information
Israel
Medical Center, The Nuclear Research Center
Dimona, Israel, 70700
Sponsors and Collaborators
The S. Daniel Abraham International Center for Health and Nutrition
Harvard School of Public Health
University of Western Ontario, Canada
Soroka University Medical Center
Brigham and Women's Hospital
Harvard Medical School
The Nuclear Research Center, Dimona
Ben-Gurion University of the Negev
Investigators
Layout table for investigator information
Principal Investigator: Iris Shai, RD, PhD Ben-Gurion University of the Negev
Study Chair: Meir J Stampfer, MD, DrPH Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
Study Chair: David Spence, MD Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, London, Canada
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00160108    
Other Study ID Numbers: DR300-3
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: March 20, 2018
Last Verified: September 2006